Stock listing
C4X Stock Price, News, Filings & Events — Valerio Therapeutics
Selected listing: C4X · GETTEX · EUR · DE
This page tracks Valerio Therapeutics's C4X:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following C4X:GETTEX. C4X:GETTEX is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- C4X:GETTEX
- Asset type
- Stock
- Market cap
- $464.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Valerio Therapeutics C4X:GETTEX stock context
This page tracks Valerio Therapeutics's C4X:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following C4X:GETTEX. C4X:GETTEX is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Valerio Therapeutics
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platfo...
August 24, 2026
Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Ac...
August 17, 2026
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
July 16, 2026
Valerio Therapeutics Announces Binding Offer for the Proposed Acquisition of Etherna Immunotherapies, Creating a Global Leader in Targete...
July 1, 2026
Valerio Therapeutics : announces binding offer for the proposed acquisition of Etherna Immunotherapies, creating a global leader in targe...
July 1, 2026
Research Valerio Therapeutics
Valerio Therapeutics investor report
Review AI stock analysis and investor report context for C4X:GETTEX.
Valerio Therapeutics company profile
View the public company page for Valerio Therapeutics on 6ix.
Valerio Therapeutics news
Read company news and market updates connected to Valerio Therapeutics.
Valerio Therapeutics investor events
Find investor webinars, events, and replay context for Valerio Therapeutics.
Alternate listings
ALVIO:EURONEXT
FR · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
A0HMXA:LSX
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
A0HMXA:LS
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
0NWK:LSE
GB · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
C4X:MUN
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
C4X:FWB
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
C4X:SWB
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.
ALVIOP:TURQUOISE
GB · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is C4X:GETTEX.